Neuehealth Inc ( (NEUE) ) has released its Q1 earnings. Here is a breakdown of the information Neuehealth Inc presented to its investors.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
NeueHealth Inc., a value-driven healthcare company, focuses on providing high-quality, coordinated care across the ACA Marketplace, Medicare, and Medicaid sectors. In its first quarter of 2025, NeueHealth reported a strong performance, marked by a significant increase in consumer engagement and continued profitability in Adjusted EBITDA. The company served approximately 709,000 consumers, marking a 51% increase compared to the same period last year, and achieved positive Adjusted EBITDA for the fifth consecutive quarter, underscoring its robust financial health.
The company’s revenue for the quarter totaled $215.8 million, a decrease from $245.1 million in the previous year, primarily due to a reduction in ACO REACH revenue. Despite this, NeueHealth managed to improve its Adjusted EBITDA to $13.5 million from $3.7 million in the prior year, demonstrating effective cost management and operational efficiency. However, the company recorded a net loss of $10.8 million, which was higher than the $4.2 million loss reported in the first quarter of 2024.
NeueHealth’s strategic focus on expanding its consumer base and enhancing its care model has resulted in a notable increase in value-based consumers served, from 360,000 to 571,000 year-over-year. The company also reported a rise in enablement services lives, reaching 138,000 from 109,000. These metrics highlight NeueHealth’s commitment to broadening its reach and impact within the healthcare industry.
Looking ahead, NeueHealth’s management remains optimistic about sustaining long-term growth and strengthening industry relationships. The company aims to continue leveraging its consumer-centric care model to drive further success and innovation in the healthcare sector.